Physician profile
Myron Chwe
NPI 1013982750
$1,551.61
in general payments reported to CMS, 2019-2025
28 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $98.00 · 2021: $110 · 2022: $309 · 2023: $269 · 2024: $231 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $290.78 | 2019-2023 | Liletta, Lo Loestrin Fe |
| Organon LLC | $233.75 | 2021-2024 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $171.18 | 2019-2025 | |
| Amgen INC. | $101.49 | 2019-2024 | Prolia, Evenity |
| Astellas Pharma US INC | $90.28 | 2020-2025 | Veozah |
| Shield Therapeutics INC | $64.03 | 2023-2025 | Accrufer |
| Heron Therapeutics, INC. | $59.66 | 2022-2025 | Aponvie |
| Pfizer INC. | $51.85 | 2024-2025 | |
| Minerva Surgical, INC | $39.27 | 2019-2023 | |
| Scynexis, INC. | $36.08 | 2022 | |
| Allergan, INC. | $35.31 | 2019-2020 | |
| Monaghan Medical Corporation | $33.34 | 2024 | Aeroeclipse |
| Exact Sciences Corporation | $32.93 | 2023-2025 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $31.78 | 2025 | Zurzuvae |
| Integra Lifesciences Corporation | $30.36 | 2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $27.17 | 2019-2020 | |
| Therapeuticsmd, INC. | $25.51 | 2019 | |
| Northgate Technologies, INC. | $24.63 | 2024 | Stimsite |
| Mylan Pharmaceuticals INC. | $24.36 | 2019-2022 | |
| Exeltis, USA INC. | $23.53 | 2025 | Slynd |
| Agile Therapeutics, INC. | $19.88 | 2022 | |
| Coopersurgical, INC. | $19.10 | 2025 | Endosee |
| Conmed Corporation | $17.90 | 2025 | Vcare, Visiclear, Airseal |
| Evofem Biosciences, INC. | $16.69 | 2021 | |
| Hologic Sales and Service, LLC | $14.20 | 2024 | Acessa Provu System |
| Axonics, INC. | $13.78 | 2023 | Axonics |
| Lupin INC. | $11.86 | 2019 | |
| Coloplast Corp | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Myron Chwe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.